6125 SARS-CoV-2 S1 IgG

Intended Use:

The AESKULISA SARS-CoV-2 S1 IgG test is a qualitative and quantitative immunoassays for the demonstration of human IgG antibodies in serum or plasma directed against the S1 domain of the spike protein of SARS-CoV-2. The AESKULISA SARS-CoV-2 S1 IgG test serves for confirmation of a contact with the pathogen and supports in immune status determination.

Recombinant Antigens:

Recombinant S1 domain of the spike protein of SARS-CoV-2

Native Antigens:

n.a.